ArticlePharmaceuticals (Basel, Switzerland)2026

Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy.

Serena Di Iasio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.